| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,495 |
2,148 |
$314K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,468 |
2,145 |
$273K |
| D0999 |
Unspecified diagnostic procedure, by report |
842 |
699 |
$180K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,265 |
869 |
$22K |
| 99441 |
|
30 |
28 |
$5K |
| 99215 |
Prolong outpt/office vis |
21 |
20 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
71 |
71 |
$173.84 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
151 |
148 |
$19.70 |
| 90688 |
|
92 |
92 |
$6.60 |
| 80061 |
Lipid panel |
24 |
24 |
$0.00 |
| 84439 |
|
39 |
38 |
$0.00 |
| 82570 |
|
12 |
12 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
15 |
15 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
13 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
255 |
251 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
82 |
81 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
39 |
38 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
40 |
40 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
49 |
49 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
15 |
15 |
$0.00 |
| D0210 |
Intraoral - complete series of radiographic images |
12 |
12 |
$0.00 |
| 82043 |
|
12 |
12 |
$0.00 |
| 87428 |
|
14 |
14 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
12 |
12 |
$0.00 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
12 |
12 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
14 |
13 |
$0.00 |